Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1994 Dec;72(6):521–527. doi: 10.1136/hrt.72.6.521

Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure.

H Berglund 1, O Nyquist 1, B Beermann 1, M Jensen-Urstad 1, E Theodorsson 1
PMCID: PMC1025636  PMID: 7857733

Abstract

OBJECTIVE--To examine the relation between haemodynamics and atrial natriuretic peptide concentration during short term angiotensin converting enzyme inhibition. DESIGN--Patients were randomly allocated to receive placebo or one of three doses of the angiotensin converting enzyme inhibitor ramipril. SETTING--Cardiac units of two tertiary referral hospitals. SUBJECTS--38 Patients with stable congestive heart failure caused by ischaemic heart disease. METHODS--Data were collected over a 24 hour period and assessed with the aim of distinguishing between the haemodynamic effects on plasma concentrations of atrial natriuretic peptide and the direct effects of the study drug, vasopressin concentrations, and angiotensin converting enzyme activity. RESULTS--Pulmonary capillary wedge pressure was the main predictor of the plasma concentration of atrial natriuretic peptide. A higher plasma concentration of this peptide with a given pulmonary capillary wedge pressure was found after 24 hours of treatment with 2.5 mg and 5 mg of ramipril. Plasma concentration of the active metabolite, change in arginine vasopressin concentration or degree of angiotensin converting enzyme inhibition did not significantly predict change in plasma concentration of atrial natriuretic peptide or in the ratio of atrial natriuretic peptide concentration to pulmonary capillary wedge pressure. CONCLUSIONS--A gradual increase in plasma concentration of atrial natriuretic peptide with a given pulmonary capillary wedge pressure, occurs during short term high degree inhibition of angiotensin converting enzyme. The causative mechanisms are yet to be identified. Such a change in the relation between central haemodynamics and atrial natriuretic peptide concentration may contribute to the beneficial effects of angiotensin converting enzyme inhibition in patients with congestive heart failure due to ischaemic heart disease.

Full text

PDF
523

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand I. S., Ferrari R., Kalra G. S., Wahi P. L., Poole-Wilson P. A., Harris P. C. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation. 1989 Aug;80(2):299–305. doi: 10.1161/01.cir.80.2.299. [DOI] [PubMed] [Google Scholar]
  2. Anderson J. V., Struthers A. D., Payne N. N., Slater J. D., Bloom S. R. Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. Clin Sci (Lond) 1986 May;70(5):507–512. doi: 10.1042/cs0700507. [DOI] [PubMed] [Google Scholar]
  3. Berglund H., Boukter S., Theodorsson E., Vallin H., Edhag O. Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation. Br Heart J. 1990 Jul;64(1):9–13. doi: 10.1136/hrt.64.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bolli P., Müller F. B., Linder L., Raine A. E., Resink T. J., Erne P., Kiowski W., Ritz R., Bühler F. R. The vasodilator potency of atrial natriuretic peptide in man. Circulation. 1987 Jan;75(1):221–228. doi: 10.1161/01.cir.75.1.221. [DOI] [PubMed] [Google Scholar]
  5. Dietz J. R. The effect of angiotensin II and ADH on the secretion of atrial natriuretic factor. Proc Soc Exp Biol Med. 1988 Mar;187(3):366–369. doi: 10.3181/00379727-187-42678. [DOI] [PubMed] [Google Scholar]
  6. Drexler H., Hirth C., Stasch H. P., Lu W., Neuser D., Just H. Vasodilatory action of endogenous atrial natriuretic factor in a rat model of chronic heart failure as determined by monoclonal ANF antibody. Circ Res. 1990 May;66(5):1371–1380. doi: 10.1161/01.res.66.5.1371. [DOI] [PubMed] [Google Scholar]
  7. Eckert H. G., Münscher G., Oekonomopulos R., Strecker H., Urbach H., Wissmann H. A radioimmunoassay for the angiotensin converting enzyme inhibitor ramipril and its active metabolite. Arzneimittelforschung. 1985;35(8):1251–1256. [PubMed] [Google Scholar]
  8. Francis G. S., Goldsmith S. R., Levine T. B., Olivari M. T., Cohn J. N. The neurohumoral axis in congestive heart failure. Ann Intern Med. 1984 Sep;101(3):370–377. doi: 10.7326/0003-4819-101-3-370. [DOI] [PubMed] [Google Scholar]
  9. Gaillard C. A., Koomans H. A., Mees E. J. Enalapril attenuates natriuresis of atrial natriuretic factor in humans. Hypertension. 1988 Feb;11(2):160–165. doi: 10.1161/01.hyp.11.2.160. [DOI] [PubMed] [Google Scholar]
  10. Lee M. E., Miller W. L., Edwards B. S., Burnett J. C., Jr Role of endogenous atrial natriuretic factor in acute congestive heart failure. J Clin Invest. 1989 Dec;84(6):1962–1966. doi: 10.1172/JCI114385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lee R. W., Gay R. G., Goldman S. Atrial natriuretic peptide reverses angiotensin-induced venoconstriction in dogs. Am J Physiol. 1989 Oct;257(4 Pt 2):H1062–H1067. doi: 10.1152/ajpheart.1989.257.4.H1062. [DOI] [PubMed] [Google Scholar]
  12. Lewis B. S., Ganz W., Laramee P., Cercek B., Hod H., Shah P. K., Lew A. S. Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction. Am J Cardiol. 1988 Jul 1;62(1):20–24. doi: 10.1016/0002-9149(88)91358-6. [DOI] [PubMed] [Google Scholar]
  13. Lewis B. S., Makhoul N., Dakak N., Flugelman M. Y., Yechiely H., Halon D. A., Kahana L. Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy. Am Heart J. 1992 Oct;124(4):1009–1016. doi: 10.1016/0002-8703(92)90985-5. [DOI] [PubMed] [Google Scholar]
  14. Malvano R., Zucchelli G. C., Rosa U., Salvetti A. Measurement of plasma renin activity by angiotensin I radioimmunoassay: (I) an assessment of some methodological aspects. J Nucl Biol Med. 1972 Jan-Mar;16(1):24–31. [PubMed] [Google Scholar]
  15. Mancini G. B., McGillem M. J., Bates E. R., Weder A. B., DeBoe S. F., Grekin R. J. Hormonal responses to cardiac tamponade: inhibition of release of atrial natriuretic factor despite elevation of atrial pressures. Circulation. 1987 Oct;76(4):884–890. doi: 10.1161/01.cir.76.4.884. [DOI] [PubMed] [Google Scholar]
  16. Mann F. E., Lang R. E., Leidig M., Ritz E. Effect of angiotensin I converting enzyme inhibition on circulating atrial natriuretic peptide in humans. Klin Wochenschr. 1986;64 (Suppl 6):13–15. [PubMed] [Google Scholar]
  17. Manning P. T., Schwartz D., Katsube N. C., Holmberg S. W., Needleman P. Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. Science. 1985 Jul 26;229(4711):395–397. doi: 10.1126/science.2990050. [DOI] [PubMed] [Google Scholar]
  18. McMurray J. J., Struthers A. D. Atrial natriuretic factor inhibits isoproterenol- and furosemide-stimulated renin release in humans. Hypertension. 1989 Jan;13(1):9–14. doi: 10.1161/01.hyp.13.1.9. [DOI] [PubMed] [Google Scholar]
  19. Metzger H., Maier R., Sitter C., Stern H. O. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S) -2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)--a new and highly effective angiotensin I converting enzyme inhibitor. Arzneimittelforschung. 1984;34(10B):1402–1406. [PubMed] [Google Scholar]
  20. Morris M., Cain M., Chalmers J. Complementary changes in plasma atrial natriuretic peptide and antidiuretic hormone concentrations in response to volume expansion and haemorrhage: studies in conscious normotensive and spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1987 Apr;14(4):283–289. doi: 10.1111/j.1440-1681.1987.tb00973.x. [DOI] [PubMed] [Google Scholar]
  21. Nicholls M. G., Ikram H., Fitzpatrick M. A., Crozier I. G. Converting enzyme inhibitors in heart failure. Eur Heart J. 1988 Jun;9 (Suppl H):77–83. doi: 10.1093/eurheartj/9.suppl_h.77. [DOI] [PubMed] [Google Scholar]
  22. Packer M., Medina N., Yushak M. Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. Circulation. 1985 Apr;71(4):761–766. doi: 10.1161/01.cir.71.4.761. [DOI] [PubMed] [Google Scholar]
  23. Richards A. M., Rao G., Espiner E. A., Yandle T. Interaction of angiotensin converting enzyme inhibition and atrial natriuretic factor. Hypertension. 1989 Mar;13(3):193–199. doi: 10.1161/01.hyp.13.3.193. [DOI] [PubMed] [Google Scholar]
  24. Rouleau J. L., Bichet D., Kortas C. Atrial natriuretic peptide in congestive heart failure: postural changes and reset with chronic captopril therapy. Am Heart J. 1988 May;115(5):1060–1067. doi: 10.1016/0002-8703(88)90077-4. [DOI] [PubMed] [Google Scholar]
  25. Salazar F. J., Granger J. P., Fiksen-Olsen M. J., Bentley M. D., Romero J. C. Possible modulatory role of angiotensin II on atrial peptide-induced natriuresis. Am J Physiol. 1987 Nov;253(5 Pt 2):F880–F883. doi: 10.1152/ajprenal.1987.253.5.F880. [DOI] [PubMed] [Google Scholar]
  26. Stasch J. P., Hirth-Dietrich C., Kazda S., Neuser D. Endothelin stimulates release of atrial natriuretic peptides in vitro and in vivo. Life Sci. 1989;45(10):869–875. doi: 10.1016/0024-3205(89)90200-2. [DOI] [PubMed] [Google Scholar]
  27. Tang J., Webber R. J., Chang D., Chang J. K., Kiang J., Wei E. T. Depressor and natriuretic activities of several atrial peptides. Regul Pept. 1984 Sep;9(1-2):53–59. doi: 10.1016/0167-0115(84)90007-7. [DOI] [PubMed] [Google Scholar]
  28. Theodorsson E. BASIC computer program to summarize data using nonparametric and parametric statistics including Anderson-Darling test for normality. Comput Methods Programs Biomed. 1988 Mar-Apr;26(2):207–213. doi: 10.1016/0169-2607(88)90046-6. [DOI] [PubMed] [Google Scholar]
  29. Todd P. A., Benfield P. Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders. Drugs. 1990 Jan;39(1):110–135. doi: 10.2165/00003495-199039010-00009. [DOI] [PubMed] [Google Scholar]
  30. Uehlinger D. E., Weidmann P., Gnaedinger M. P., Shaw S., Lang R. E. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. J Clin Endocrinol Metab. 1986 Sep;63(3):669–674. doi: 10.1210/jcem-63-3-669. [DOI] [PubMed] [Google Scholar]
  31. Volpe M., Pepino P., Lembo G., Pignalosa S., Mele A. F., Rubattu S., Condorelli G., Covino E., Trimarco B. Modulatory role of angiotensin-II in the secretion of atrial natriuretic factor in rabbits. Endocrinology. 1991 May;128(5):2427–2431. doi: 10.1210/endo-128-5-2427. [DOI] [PubMed] [Google Scholar]
  32. Volpe M., Tritto C., DeLuca N., Rubattu S., Mele A. F., Lembo G., Enea I., deCampora P., Rendina V., Romano M. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure. Circulation. 1992 Dec;86(6):1800–1809. doi: 10.1161/01.cir.86.6.1800. [DOI] [PubMed] [Google Scholar]
  33. Waldman H. M., Palacios I. F., Block P. C., Wilkins G. T., Homcy C. J., Graham R. M., Fifer M. A. Responsiveness of plasma atrial natriuretic factor to short-term changes in left atrial hemodynamics after percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol. 1988 Sep;12(3):649–655. doi: 10.1016/s0735-1097(88)80051-2. [DOI] [PubMed] [Google Scholar]
  34. Wharton J., Anderson R. H., Springall D., Power R. F., Rose M., Smith A., Espejo R., Khaghani A., Wallwork J., Yacoub M. H. Localisation of atrial natriuretic peptide immunoreactivity in the ventricular myocardium and conduction system of the human fetal and adult heart. Br Heart J. 1988 Oct;60(4):267–274. doi: 10.1136/hrt.60.4.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wilkins M. R., Lewis H. M., West M. J., Kendall M. J., Lote C. J. Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives. J Hum Hypertens. 1987 Jun;1(1):47–51. [PubMed] [Google Scholar]
  36. de Bold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981 Jan 5;28(1):89–94. doi: 10.1016/0024-3205(81)90370-2. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES